Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia

BMJ Case Rep. 2012 Mar 20:2012:bcr1120115097. doi: 10.1136/bcr.11.2011.5097.

Abstract

The authors used vancomycin (VCM) to treat Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia. Pulmonary infiltrates are found in about one-third of patients with haematological pathologies accompanying C jeikeium bacteraemia. Although linezolid and daptomycin are antimicrobial alternatives for treating Corynebacterium infections, the authors believe that VCM is the best choice for immediate treatment success and to prevent pulmonary infiltrates from developing in the presence of bloodstream infection with Corynebacteria in patients with haematological malignancies.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / complications*
  • Bacteremia / drug therapy
  • Bacteremia / microbiology*
  • Corynebacterium / isolation & purification*
  • Corynebacterium Infections / complications*
  • Corynebacterium Infections / drug therapy
  • Corynebacterium Infections / microbiology*
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Respiratory Tract Infections / complications*
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / microbiology*
  • Tomography, X-Ray Computed
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin